The role of granulocyte-macrophage colony-stimulating factor-stimulated progenitor cells in oncology.
Western Pennsylvania Cancer Institute, West Penn Hospital, Pittsburgh 15224.
C S
CS
Rosenfeld
J
J
Nemunaitis
D000818:Animals; D001793:Blood Preservation; D001804:Blood Transfusion, Autologous / Q000379:methods; D002986:Clinical Trials as Topic; D015925:Cryopreservation; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007937:Leukapheresis / Q000379:methods; D008297:Male; D009369:Neoplasms / Q000628:therapy*; D009360:Neoplastic Cells, Circulating; D010198:Pancytopenia / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use
D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor